Gibbs Wealth Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$568K Buy
+9,585
New +$622K 0.07% 256
2025
Q3
Sell
-11,614
Closed -$927K 366
2025
Q2
$927K Buy
11,614
+1,620
+16% +$135K 0.18% 137
2025
Q1
$859K Buy
9,994
+2,619
+36% +$215K 0.21% 109
2024
Q4
$576K Buy
7,375
+1,270
+21% +$98.6K 0.16% 144
2024
Q3
$440K Buy
6,105
+715
+13% +$50.6K 0.14% 163
2024
Q2
$371K Buy
5,390
+1,337
+33% +$90.6K 0.15% 157
2024
Q1
$294K Buy
+4,053
New +$271K 0.17% 141

Other funds holding PBH

Gibbs Wealth Management's PBH Position: Q1 2026 in Review

Gibbs Wealth Management opened a new position in Prestige Consumer Healthcare (PBH) in Q1 2026: 9,585 shares worth $568K. The stake represents 0.07% of the portfolio and ranks #256 among its holdings. This is a return to the name: Gibbs Wealth Management previously reported a position in PBH as recently as Q2 2025.

Gibbs Wealth Management first reported a position in PBH in Q1 2024 and has held it in 7 quarters since. The position peaked at $927K in Q2 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Gibbs Wealth Management held 9,585 shares of Prestige Consumer Healthcare worth $568K as of Q1 2026.
  • Prestige Consumer Healthcare was a new Gibbs Wealth Management position in Q1 2026.
  • Prestige Consumer Healthcare made up 0.07% of Gibbs Wealth Management's portfolio in Q1 2026, its #256 holding.
  • Gibbs Wealth Management first reported a position in Prestige Consumer Healthcare in Q1 2024 and has held it in 7 quarters since.
  • Gibbs Wealth Management's Prestige Consumer Healthcare position peaked at $927K in Q2 2025.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.